RecruitingNot ApplicableNCT06139354

Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault

Pilot Testing of a Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault

Sponsor

University of Arkansas

Enrollment

45 participants

Start Date

Oct 4, 2024

Study Type

INTERVENTIONAL

Conditions

HIV

Summary

The goal of this trial is to pilot a digital, interactive patient-provider HIV PEP decision aid. The decision aid will incorporate five sections of content: 1) key clinical factors input by providers; 2) tailored multimedia-based HIV risk sharing information; 3) standardized multimedia educational messaging regarding the effectiveness, risks, and benefits of HIV PEP; 4) direct comparisons of priorities (e.g., physical well-being - "I want to do everything I can to prevent HIV," privacy - "I don't want others to know about the exposure," or cost - "I can't afford the pills'') completed by patients; and 5) tailored feedback regarding patient priorities for use in shared clinical decision making.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a decision aid tool designed to help sexual assault survivors and their healthcare providers make informed decisions about HIV post-exposure prophylaxis (PEP) — a short course of medication taken after a potential HIV exposure to prevent infection. The tool aims to improve communication and shared decision-making during a difficult time. **You may be eligible if...** - You are 18 or older - You are seeking care at the study clinic (DCFNE) following a sexual assault - You meet CDC criteria for HIV PEP: you are seeking care within 72 hours of the assault and there was a potential exposure to HIV - You are able to participate and give consent in English **You may NOT be eligible if...** - You are under 18 years old - More than 72 hours have passed since the assault (PEP is not effective after 72 hours) - The type of assault carries minimal HIV exposure risk - You cannot participate in English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALdecision aid

A digital, interactive patient-provider HIV PEP decision aid. The decision aid will incorporate five sections of content: 1) key clinical factors input by providers; 2) tailored HIV risk sharing information; 3) standardized multimedia educational messaging regarding the effectiveness, risks, and benefits of HIV PEP; 4) direct comparisons of priorities (e.g., physical well-being - "I want to do everything I can to prevent HIV," privacy - "I don't want others to know about the exposure," or cost - "I can't afford the pills'') completed by patients; and 5) tailored feedback regarding patient priorities for use in shared clinical decision making.

Locations(1)

District of Columbia Forensic Nurse Examiners

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06139354

Related Trials

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

NCT064443602 locations

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

NCT0739095512 locations

Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection

NCT007890091 location

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

NCT000012812 locations

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

NCT000065181 location